Genus PLC
21 March 2001
FOR IMMEDIATE RELEASE 21 March 2001
GENUS plc
Sale of Human Pharmaceuticals Business
The Distribution Division of Genus plc completed the sale of the stock and
goodwill of its £2.6 million per year human pharmaceuticals wholesale business
on 15 March to Audenbrook Ltd. The consideration was £352,000 in cash.
Genus Distribution is a marketer and wholesale distributor of veterinary
products. The sale of this non-core human pharmaceutical business will enable
the Division's new management to concentrate its efforts on the recovery of
the Division's principal businesses in the veterinary sector.
- END -
___________________________________________________________________________
FOR FURTHER INFORMATION, PLEASE CONTACT:
Genus
Richard Wood, Chief Executive Tel: +44 (0)1270 536501
Buchanan Communications
Charles Ryland / Catherine Miles Tel: +44 (0)207 466 5000
Notes to Editors:
In July 2000 Genus moved from OFEX to the Alternative Investment Market of the
London Stock Exchange and now trades in over 70 countries through its three
divisions:
* Genus Breeding is the global market leader in cattle Breeding. Its
cutting edge technology is being used to improve the quality of beef and dairy
herds worldwide.
* Genus Consulting offers advice to the complete food chain including
solutions for farmers, growers, food manufacturers, agri-business and national
and international policy makers.
* Genus Distribution is a marketer and wholesale distributor of
veterinary products.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.